IQVIA Holdings Inc. operates in 3 segments: Technology & Analytics Solutions; Research & Development Solutions; and Contract Sales & Medical Solutions.
Paying user area
Try for free
IQVIA Holdings Inc. pages available for free this week:
- Income Statement
- Common-Size Balance Sheet: Assets
- Analysis of Profitability Ratios
- Analysis of Solvency Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Analysis of Geographic Areas
- Enterprise Value to FCFF (EV/FCFF)
- Return on Equity (ROE) since 2013
- Price to Earnings (P/E) since 2013
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to IQVIA Holdings Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Segment Profit Margin
Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
---|---|---|---|---|---|
Technology & Analytics Solutions | |||||
Research & Development Solutions | |||||
Contract Sales & Medical Solutions |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment profit margin | Technology & Analytics Solutions | Technology & Analytics Solutions segment profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. |
Research & Development Solutions | Research & Development Solutions segment profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. | |
Contract Sales & Medical Solutions | Contract Sales & Medical Solutions segment profit margin ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022. |
Segment Profit Margin: Technology & Analytics Solutions
Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Segment profit | |||||
Revenues | |||||
Segment Profitability Ratio | |||||
Segment profit margin1 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Segment profit margin = 100 × Segment profit ÷ Revenues
= 100 × ÷ =
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment profit margin | Technology & Analytics Solutions | Technology & Analytics Solutions segment profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. |
Segment Profit Margin: Research & Development Solutions
Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Segment profit | |||||
Revenues | |||||
Segment Profitability Ratio | |||||
Segment profit margin1 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Segment profit margin = 100 × Segment profit ÷ Revenues
= 100 × ÷ =
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment profit margin | Research & Development Solutions | Research & Development Solutions segment profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. |
Segment Profit Margin: Contract Sales & Medical Solutions
Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Segment profit | |||||
Revenues | |||||
Segment Profitability Ratio | |||||
Segment profit margin1 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Segment profit margin = 100 × Segment profit ÷ Revenues
= 100 × ÷ =
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment profit margin | Contract Sales & Medical Solutions | Contract Sales & Medical Solutions segment profit margin ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022. |
Revenues
Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
---|---|---|---|---|---|
Technology & Analytics Solutions | |||||
Research & Development Solutions | |||||
Contract Sales & Medical Solutions | |||||
Total |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
Segment profit
Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
---|---|---|---|---|---|
Technology & Analytics Solutions | |||||
Research & Development Solutions | |||||
Contract Sales & Medical Solutions | |||||
Total |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).